Literature DB >> 8523111

Drug therapy and cerebral perfusion in obsessive-compulsive disorder.

V Molina1, R Montz, M Martín-Loeches, A Jiménez-Vicioso, J L Carreras, F J Rubia.   

Abstract

Cerebral perfusion in a previously untreated patient with obsessive-compulsive disorder was studied qualitatively and semi-quantitatively with SPECT before, and during and 6 wk after treatment with clomipramine. The patient's symptoms disappeared while on medication and relapsed after drug withdrawal. At baseline, there was an increased perfusion ratio in the bilateral orbitofrontal, anterior cingular, frontotemporal and right caudate regions. These alterations disappeared during drug therapy. After treatment discontinuation and symptomatic relapse, the same pattern of hyperactivity was found. Semiquantitative measurements after treatment withdrawal showed a return to perfusion values similar to those observed before treatment in subcortical structures. In cortical areas, this level was not completely achieved. Subtraction SPECT images showed perfusion changes at the orbitofrontal, caudate and thalamic levels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8523111

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

1.  Fusion of coregistered cross-modality images using a temporally alternating display method.

Authors:  J S Lee; B Kim; Y Chee; C Kwark; M C Lee; K S Park
Journal:  Med Biol Eng Comput       Date:  2000-03       Impact factor: 2.602

2.  Electroconvulsive therapy on severe obsessive-compulsive disorder comorbid depressive symptoms.

Authors:  Xiaohui Liu; Hong Cui; Qiang Wei; Ying Wang; Keyong Wang; Chen Wang; Chunyan Zhu; Xinhui Xie
Journal:  Psychiatry Investig       Date:  2014-04-11       Impact factor: 2.505

Review 3.  [Neurobiology of obsessive-compulsive disorder].

Authors:  S Karch; O Pogarell
Journal:  Nervenarzt       Date:  2011-03       Impact factor: 1.214

4.  Augmentation effect of repetitive transcranial magnetic stimulation over the orbitofrontal cortex in drug-resistant obsessive-compulsive disorder patients: a controlled investigation.

Authors:  Chiara Ruffini; Marco Locatelli; Adelio Lucca; Francesco Benedetti; Chiara Insacco; Enrico Smeraldi
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

5.  The associative and limbic thalamus in the pathophysiology of obsessive-compulsive disorder: an experimental study in the monkey.

Authors:  J Y Rotge; B Aouizerate; V Amestoy; V Lambrecq; N Langbour; T H Nguyen; S Dovero; L Cardoit; J Tignol; B Bioulac; P Burbaud; D Guehl
Journal:  Transl Psychiatry       Date:  2012-09-25       Impact factor: 6.222

6.  Impact of treatment on resting cerebral blood flow and metabolism in obsessive compulsive disorder: a meta-analysis.

Authors:  A L van der Straten; D Denys; G A van Wingen
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

7.  Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram.

Authors:  Paul D Carey; James Warwick; Dana J H Niehaus; Geoffrey van der Linden; Barend B van Heerden; Brian H Harvey; Soraya Seedat; Dan J Stein
Journal:  BMC Psychiatry       Date:  2004-10-14       Impact factor: 3.630

8.  The neural correlates of obsessive-compulsive disorder: a multimodal perspective.

Authors:  P S Moreira; P Marques; C Soriano-Mas; R Magalhães; N Sousa; J M Soares; P Morgado
Journal:  Transl Psychiatry       Date:  2017-08-29       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.